Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BridgeBio Pharma ( (BBIO)) has shared an ...
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial In this phase III trial, ...
It seems that frustrated New York Yankees fans were given a big reason to expect a far better season from shortstop Anthony Volpe next year. Before he was promoted two years ago, Volpe was viewed as ...
BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the most promising long-term stocks to buy. On September 6, BridgeBio Pharma announced that its investigational, orally-administered therapy, called ...
– evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in ITT and ESR1-mutated populations in the post-CDK inhibitor setting, compared with standard of ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Roivant Sciences ( (ROIV)) has provided ...
LEO Pharma A/S, a global leader in medical dermatology, today presented two late-breaking presentations showcasing the results of a Phase 2b dose finding trial evaluating the efficacy and safety of ...
HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy The ...
During the April “Hands Off” protest in Jackson Township, I walked through the entire crowd with a small Revere Ware pot and stainless steel rod calmly but audibly tapping the noisemaker and inviting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback